Lanoxin: Restore Cardiac Rhythm and Improve Heart Function
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.52 | $47.19 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $62.92 $57.23 (9%) | 🛒 Add to cart |
| 180 | $0.44 | $94.38 $78.32 (17%) | 🛒 Add to cart |
| 270 | $0.41 | $141.57 $110.45 (22%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $188.76 $141.57 (25%) | 🛒 Add to cart |
Synonyms | |||
Lanoxin (digoxin) is a time-tested cardiac glycoside derived from the leaves of Digitalis lanata. It remains a cornerstone in the management of various cardiac conditions, primarily due to its positive inotropic and negative chronotropic effects. This medication increases the force of myocardial contraction and slows the heart rate, making it a vital therapeutic agent for treating heart failure and controlling ventricular response in atrial fibrillation. Its precise mechanism of action, through inhibition of the sodium-potassium ATPase pump, offers a unique pharmacological profile that, when monitored correctly, provides significant clinical benefits for appropriate patients.
Features
- Active Ingredient: Digoxin.
- Pharmacological Class: Cardiac glycoside.
- Mechanism of Action: Inhibits sodium-potassium ATPase pump, leading to increased intracellular sodium. This drives calcium influx via the sodium-calcium exchanger, resulting in increased intracellular calcium, which enhances myocardial contractility (positive inotropy). It also increases vagal tone, slowing conduction through the atrioventricular (AV) node.
- Standard Formulations: Oral tablets (62.5 mcg, 125 mcg, 250 mcg), and an injectable solution for IV or IM administration.
- Bioavailability: Oral tablets have 60-80% bioavailability.
- Half-life: Approximately 36-48 hours in patients with normal renal function, necessitating a loading dose for rapid digitalization in urgent cases.
- Therapeutic Index: Narrow, requiring careful dosing and monitoring of serum concentrations.
- Primary Excretion: Renal; dosage must be adjusted in patients with renal impairment.
Benefits
- Improves Cardiac Output: Enhances the strength of heart muscle contractions, leading to more efficient pumping of blood throughout the body, which alleviates symptoms of heart failure such as dyspnea and fatigue.
- Controls Ventricular Rate: Effectively slows the heart rate in patients with atrial fibrillation and atrial flutter, improving ventricular filling and reducing palpitations.
- Long-Standing Efficacy: Decades of clinical use have solidified its role and safety profile when administered and monitored according to established guidelines.
- Oral Administration Option: Available in a convenient oral tablet form for long-term maintenance therapy outside of a hospital setting.
- Adjunctive Therapy: Can be used effectively in combination with other heart failure medications like diuretics, ACE inhibitors, and beta-blockers to provide comprehensive management.
Common use
Lanoxin (digoxin) is indicated for the treatment of mild to moderate heart failure. It is used to improve hemodynamics and clinical symptoms in patients who have not responded adequately to first-line therapies like ACE inhibitors and diuretics. Its second primary indication is for the control of resting ventricular rate in patients with chronic atrial fibrillation. It is particularly useful in patients with concomitant heart failure where other rate-control agents like beta-blockers or non-dihydropyridine calcium channel blockers may be poorly tolerated or contraindicated.
Dosage and direction
Dosing is highly individualized and must be based on clinical factors, including the patient’s age, weight, renal function, and concomitant medications.
- Digitalization (Loading Dose): For rapid effect in atrial fibrillation, a loading dose is used. A common regimen is 10-15 mcg/kg of ideal body weight administered orally in divided doses (e.g., 50% initially, then 25% every 6-8 hours) with careful assessment of clinical response and monitoring for toxicity.
- Maintenance Dosing: For most adults with normal renal function (creatinine clearance >50 mL/min), the typical maintenance dose is 125 mcg to 250 mcg once daily. For elderly patients or those with renal impairment, a dose of 62.5 mcg daily or 125 mcg every other day is often appropriate.
- Monitoring: Serum digoxin concentration measurements are crucial. Blood should be drawn at least 6-8 hours after the last dose and just before the next scheduled dose (trough level). The generally accepted therapeutic range is 0.5 to 0.9 ng/mL for heart failure. Higher levels (up to 2.0 ng/mL) may be targeted for atrial fibrillation rate control but are associated with an increased risk of toxicity.
- Administration: Tablets should be taken consistently with respect to meals. The IV formulation must be administered slowly and is reserved for urgent situations.
Precautions
- Renal Impairment: Digoxin is primarily excreted by the kidneys. Dosage must be reduced and monitoring must be more frequent in patients with renal insufficiency. Estimated creatinine clearance should be calculated to guide dosing.
- Electrolyte Imbalances: Hypokalemia, hypomagnesemia, and hypercalcemia predispose patients to digoxin toxicity, even at therapeutic serum levels. These electrolytes must be monitored and corrected, especially when patients are on concomitant diuretic therapy.
- Thyroid Disorders: Hypothyroidism can reduce digoxin clearance, increasing the risk of toxicity. Hyperthyroidism may increase digoxin requirements.
- Underlying Cardiac Conditions: Pre-existing sinus node disease or AV block (e.g., sick sinus syndrome) may be exacerbated by the vagotonic effects of digoxin.
- Pregnancy and Lactation: Digoxin crosses the placenta and is excreted in breast milk. It should be used during pregnancy only if clearly needed and with careful monitoring. Use during lactation is generally considered compatible.
Contraindications
Lanoxin is contraindicated in the following conditions:
- Ventricular fibrillation.
- Known hypersensitivity to digoxin or other digitalis preparations.
- Second- or third-degree AV block (in the absence of a functioning permanent pacemaker).
- Wolff-Parkinson-White (WPW) syndrome with atrial fibrillation (digoxin can accelerate conduction down the accessory pathway, leading to ventricular fibrillation).
- Constrictive pericarditis and cardiac amyloidosis.
Possible side effect
Side effects are often dose-related and are manifestations of toxicity.
- Cardiac: Proarrhythmic effects are the most serious. These include PVCs, ventricular bigeminy/trigeminy, ventricular tachycardia, AV nodal blockade, and junctional or accelerated idioventricular rhythms.
- Gastrointestinal: Anorexia, nausea, vomiting, abdominal pain, and diarrhea are often early signs of toxicity.
- Neurological/CNS: Fatigue, malaise, headache, dizziness, visual disturbances (e.g., yellow-green halos around lights—xanthopsia), confusion, and nightmares.
- Other: Gynecomastia (rare).
Drug interaction
Digoxin has numerous significant interactions. Serum level monitoring is essential when adding or discontinuing interacting drugs.
- QT-prolonging agents (e.g., amiodarone, quinidine, verapamil, dronedarone): These drugs can significantly increase digoxin serum levels by reducing its renal and non-renal clearance.
- Diuretics (especially loop and thiazide diuretics): Can cause hypokalemia and hypomagnesemia, increasing the risk of digoxin toxicity.
- Macrolide/ Tetracycline antibiotics, Propafenone: Can increase digoxin levels by altering gut flora that metabolize digoxin.
- Sympathomimetics (e.g., epinephrine): Can increase the risk of arrhythmias.
- Succinylcholine: May potentiate arrhythmogenic effects.
- Thyroid hormones: May decrease serum digoxin levels.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered on that same day. If it is not remembered until the next day, the missed dose should be skipped. The patient should never take a double dose to make up for a forgotten one, as this significantly increases the risk of toxicity.
Overdose
Digoxin overdose is a life-threatening medical emergency.
- Symptoms: Severe nausea and vomiting, hyperkalemia, and a wide variety of cardiac arrhythmias (e.g., severe bradycardia, AV block, ventricular tachycardia/fibrillation).
- Treatment:
- Supportive Care: Activated charcoal if ingestion was recent. Continuous cardiac monitoring.
- Correct Electrolytes: Treat hyperkalemia with standard therapies (insulin/dextrose, sodium bicarbonate, kayexalate). Note: Calcium administration is traditionally avoided as it may worsen cardiotoxicity (“stone heart”).
- Digoxin-Specific Antibody Fragments (Digibind®/DigiFab®): This is the definitive treatment for serious, life-threatening overdose (e.g., ventricular arrhythmias, advanced heart block, potassium >5.0 mEq/L). It binds digoxin molecules, rendering them inactive.
Storage
Store Lanoxin tablets at room temperature (20°-25°C or 68°-77°F), in a tightly closed container, protected from light and moisture. Keep all medications out of the reach of children and pets. Do not use after the expiration date printed on the container.
Disclaimer
This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or stopping any medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision and are not liable for any damages or negative consequences from any treatment, action, application, or preparation, to any person reading or following the information in this document.
Reviews
- “As a cardiologist with over 30 years of practice, I continue to find digoxin invaluable for a specific subset of my heart failure and AFib patients. Its inotropic effect, when used at low doses with careful therapeutic drug monitoring, provides a unique benefit that is not replicated by newer agents.” – Dr. E. Vance, MD, Cardiology.
- “This medication gave me my life back. The constant shortness of breath and racing heart from my atrial fibrillation are now under control. I get my blood levels checked regularly and have had no issues.” – Patient M, 68.
- “A classic drug that requires respect. Its narrow therapeutic window demands vigilance from both the prescriber and the patient. When used correctly, it is extremely effective. When mismanaged, the consequences are severe.” – Clinical Pharmacist, Major Hospital System.
- “After trying other medications that caused side effects I couldn’t tolerate, my doctor started me on a low dose of Lanoxin. It has effectively managed my heart rate without the fatigue I experienced before.” – Patient R, 72.